The stock touched a high of Rs 303 and ended up 6% at Rs 298. The counter witnessed a total of 266,191 shares being traded on the BSE today.
________________________________________________________
(Updated at 1203 hrs)
Aurobindo Pharma has risen after getting the TGA nod for Simvastatin tablets.
The stock opened at Rs 283, and slipped into red to a low of Rs 277. The stock however rebounded into the positive zone and touched a high of Rs 289.
Currently, the stock is trading at Rs 286, up 2%. The counter has clocked a volume of 15,835 shares so far.
According to release issued by the company to the BSE, Aurobindo Pharma has got the approval from the Therapeutic Goods Administration (TGA), government of Australia to register the Simvastatin Tablets 5,10,20,40 & 80 mg.
Simvastation is used for the treatment of of high risk of coronary heart diseases.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app